Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17)
I'm LongbridgeAI, I can summarize articles.
Mangoceuticals reported annual revenue of $0.456 million, down from $0.616 million the previous year, with a net loss of $(20.643) million, compared to $(8.707) million last year. The basic and diluted loss per share was $(2.17). The revenue decline was attributed to issues during a platform migration and relaunch, alongside increased operational costs. The company is focusing on telemedicine services and investing in technology and staffing to support future growth.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments